Biohaven Pharmaceuticals Named Murphy's 'Innovator of the Month'
New Haven innovator Biohaven Pharmaceuticals, founded on research and intellectual property from its CEO’s research in the Yale Department of Psychiatry, was named “Innovator of the Month” in December by U.S. Senator Chris Murphy, D-Conn.
Yale Study: Ketamine Disinhibits Dendrites and Enhances Calcium Signals in Prefrontal Dendritic Spines
In a study published in Nature Communications, Alex Kwan, PhD, Associate Professor of Psychiatry, and his research team found that within an hour after a mouse received ketamine, there is a substantial increase in the amount of calcium that goes into the dendritic spines for neurons in the prefrontal cortex.
Seltzer Honored With Outstanding Clinical Preceptor Award
Aaron Seltzer, LCSW, a clinical social worker who primarily works in the Behavioral Care Unit (BCU) in the Emergency Department at YNHH’s St. Raphael’s campus, was honored with the Outstanding Clinical Preceptor Award at the 2019 Yale Physician Associate Graduation Ceremony held December 12, 2019.
Yale Psychiatry to Launch Public Psychiatry Track
The Yale Department of Psychiatry is creating a new track for residents who are interested in the field of Public/Community Psychiatry, broadly defined as the treatment of individuals with serious mental illness and substance use disorders who receive services supported by public funds.
Yale Review: How Brain Alterations Contribute to Suicidal Thoughts and Behaviors
How brain alterations contribute to suicidal thoughts and behaviors is the subject of a new published review of brain scanning studies by Yale and international researchers. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience, and Professor of Psychiatry, in the Child Study Center and of Radiology and Biomedical Imaging at Yale, is the paper's lead and corresponding author.
Yale Researchers Measure Ketamine's Effects on a Glutamate Receptor
Sophie Holmes, PhD, Associate Research Scientist in Psychiatry, and Irina Esterlis, PhD, Associate Professor of Psychiatry, are the first and senior authors, respectively, of a study published in Journal of Cerebral Blood Flow & Metabolism that measured the effects of the anesthetic ketamine on a glutamate receptor.
BBRF Honors Krystal with 2019 Colvin Prize for Outstanding Achievement in Mood Disorders Research
The Brain & Behavior Research Foundation (BBRF) has awarded its 2019 Colvin Prize for Outstanding Achievement in Mood Disorders Research to John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry and of Neuroscience at Yale School of Medicine.